René Bernards

2023

In 2023, René Bernards earned a total compensation of $62.5K as Director at LIXTE BIOTECHNOLOGY HOLDINGS, a 53% decrease compared to previous year.

Compensation breakdown

Other$62,500
Total$62,500

Bernards received $62.5K in other compensation, accounting for 100% of the total pay in 2023.

Rankings

In 2023, René Bernards' compensation ranked 2,913th out of 2,978 executives tracked by ExecPay. In other words, Bernards earned more than 2.2% of executives.

ClassificationRankingPercentile
All
2,913
out of 2,978
2nd
Division
Manufacturing
1,617
out of 1,637
1st
Major group
Chemicals And Allied Products
896
out of 906
1st
Industry group
Drugs
860
out of 869
1st
Industry
Pharmaceutical Preparations
620
out of 627
1st
Source: SEC filing on November 4, 2024.

Bernards' colleagues

We found four more compensation records of executives who worked with René Bernards at LIXTE BIOTECHNOLOGY HOLDINGS in 2023.

2023

Yun Yen

LIXTE BIOTECHNOLOGY HOLDINGS

Director

2023

Regina Brown

LIXTE BIOTECHNOLOGY HOLDINGS

Director

2023

Stephen Forman

LIXTE BIOTECHNOLOGY HOLDINGS

Director

2023

Bas der Baan

LIXTE BIOTECHNOLOGY HOLDINGS

Director

News

You may also like